Evidence map›Paper›PMID 38721373›Full record

ArticleACS catalysis2024

Double Catalytic Activity Unveiled: Synthesis, Characterization, and Catalytic Applications of Iridium Complexes in Transfer Hydrogenation and Photomediated Transformations.

Laura Blanco, Andrea Uroz, Kevin Gutiérrez, Silvia Cabrera, Alba Collado, José Alemán

Abstract read
In one paragraph

Article in ACS catalysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura BlancoInorganic Chemistry Department, Sciences Faculty, Universidad Autónoma de Madrid, Madrid 28049, Spain.ORCID https://orcid.org/0000-0001-6100-1742
Andrea UrozOrganic Chemistry Department, Sciences Faculty, Universidad Autónoma de Madrid, Madrid 28049, Spain.ORCID https://orcid.org/0000-0002-0054-2446
Kevin GutiérrezInorganic Chemistry Department, Sciences Faculty, Universidad Autónoma de Madrid, Madrid 28049, Spain.ORCID https://orcid.org/0009-0002-8829-4818
Silvia CabreraInorganic Chemistry Department, Sciences Faculty, Universidad Autónoma de Madrid, Madrid 28049, Spain.ORCID https://orcid.org/0000-0002-4907-2932
Alba ColladoInorganic Chemistry Department, Sciences Faculty, Universidad Autónoma de Madrid, Madrid 28049, Spain.ORCID https://orcid.org/0000-0001-6215-1822
José AlemánOrganic Chemistry Department, Sciences Faculty, Universidad Autónoma de Madrid, Madrid 28049, Spain.ORCID https://orcid.org/0000-0003-0164-1777

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iridium complexes have been demonstrated to be highly active catalysts for a wide variety of transformations. Their unique photophysical and photochemical properties render them as one of the most established photocatalysts. Moreover, iridium complexes are widely acknowledged for their efficiency in transfer hydrogenation reactions. However, the development of iridium complexes able to promote both traditional organometallic catalysis and photocatalysis is scarce. Thus, the design of iridium-based catalysts is still an active area of research. In this context, we targeted the synthesis of a family of Ir-Cp* systems to explore their (photo)catalytic applications. Here, we describe the synthesis, structural characterization, and photophysical properties of iridium complexes of formula [IrCp*Cl(N^O)]. These complexes have been applied with a double catalytic function, in transfer hydrogenation for carbonyl reduction and in different photomediated transformations.

Identifiers

PMID38721373
PMCPMC11075020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.